Robert Wilson Buys Over 1 Million Shares of CALC
Robert Wilson made a significant purchase of CALC shares, totaling over $946,000.
Key Points
- Robert Wilson bought 1,182,621 shares of CALC at $0.80 per share, totaling $946,096.80 on June 25, 2026.
- Shares of CALC traded near $0.82 on Monday, reflecting recent insider buying activity.
- Insider buying included multiple executives, and analysts maintain a positive outlook with several buy ratings.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Robert Wilson made a substantial purchase of CALC shares on June 25, 2026. He acquired 1,182,621 shares at a price of $0.80 each, amounting to a total transaction value of $946,096.80. This insider buying activity wasn't part of a pre-planned trading program.
Insider Buying and Selling at CalciMedica, Inc.
Several insiders at CALC engaged in buying activity on June 25, 2026. Among them, Rachel Leheny, the Chief Executive Officer, bought 186,729 shares at $0.80 per share. Chief Medical Officer Sudarshan Hebbar purchased 124,486 shares, while Fred Middleton added 248,972 shares to his holdings. Eric Roberts, the Chief Business Officer, also bought 186,729 shares, all at the same price.
Other Institutional Activity in CALC
Institutional investors have also been active in CALC. Jane Street Group, LLC significantly increased its holdings by 159,312 shares, now owning 178,515 shares valued at about $96,398. Vanguard Capital Management LLC opened a new position with 169,110 shares worth approximately $91,319. Renaissance Technologies LLC raised its stake by 39,775 shares, bringing its total to 128,075 shares valued at $69,161. Meanwhile, 180 Wealth Advisors, LLC expanded its holdings by 94,650 shares, ending with 126,500 shares valued at $68,310. Geode Capital Management, LLC added 23,595 shares, resulting in a total of 123,382 shares worth $66,652.
Analysts Set New Price Targets
Analysts maintain a positive outlook on CALC. On March 5, 2026, Oppenheimer maintained a 'buy' rating with a price target of $10. HC Wainwright & Co. has consistently reiterated its 'buy' rating, with a target of $16, as seen in their latest report from March 4, 2025. Lucid Capital Markets initiated coverage with a 'buy' rating and a $13 target on December 19, 2024.
Bottom Line
Robert Wilson's significant purchase of CALC shares highlights insider confidence in the company. The stock traded at $0.82 recently, reflecting a positive sentiment among insiders and analysts. While 13F filings and insider reports provide valuable insights, they reflect past actions and may not indicate current positions. Investors often track such activity for potential signals about company prospects.
Get CalciMedica, Inc. alerts
New 13F filings, insider trades, and analyst moves on $CALC, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.